Candida immunochemistry was the first microbial field to be investigated by quantitative immunoelectrophoresis (QIE), and the main purpose of this review is to discuss the methodology of human Candida precipitin analysis in the light of this development (3-7, 9, H, 12, 83). QIE techniques are now in use for study of Psei/domonas aeruginosa (39-47), mycobacteria (10,25,26, 58,59,75, 103), herpes simplex virus (53,(93)(94)(95)(96), Aclinomyces israelii (50, 51), and other microbial antigens and antibodies (47,48,54, 55,71, 84,86,98). Application and development of QIE methodology for study of raicrobial immunochemistry has been very fruitful, as shown by the discovery of a large number of new microbial antigens and a corresponding complexity of the human antibody response. (85); their conclusion was that serodiagnosis of deep Candida infection is urgently needed and appears promising, but further progress is dependent on development of suitable standardized antigens and standardized test methods. There is also an urgent need for standardized Candida antigens for evaluation of human T-cell effector action and for evaluation of immediate and Arthus-type hypersensitivity against Candida antigens. The need comprises antigens for use both in vitro and in vivo. The Standardization Committee of the International Union of Immunoiogical Societies has therefore recently established a 'subcommittee for Candida' (Chairman: Prof. J, R. Hobbs, Westminster Medical School, London) to recommend how such standards should be prepared. The present review is confined to discussing the immunochemistry of C. albkans and human precipitin analysis. Further, some implications of recent immunochemical progress for other immunoiogical tests are briefly outlined.Most studies of human Candida antibodies have been performed to evaluate the possibilities for serodiagnosis of candidiasis. From a clinical standpoint the deep-seated or systemic Candida infection offers special difficulties. These infections are claimed to be almost impossible to diagnose on clinical grounds (78, 85), and pathognomonic isolation of Candida species from normally sterile sites often fails or is misinterpreted as to diagnostic significance (85). The incidence of systemic candidiasis is rising, the mortality rate is high in untreated patients, and treatment with antifungal agents such as amphotericin B should be restricted to well-documented cases because of toxic side effects (85). Systemic candidiasis is a significant problem in transplanted patients, in patients with leukemia, and in patients undergoing open-heart surgery